Literature DB >> 22663994

Evaluation of serum cystatin C for diagnosis of acute rejection after renal transplantation.

J Liu1.   

Abstract

OBJECTIVE: To evaluate the clinical value of serum cystatin C (ScysC) for the diagnosis of an acute rejection episode after renal transplantation.
METHODS: The 76 recruited renal transplant patients included 43 without and 33 with an acute rejection episode. We determined the values of serum creatinine (Scr), blood urea nitrogen (BUN), β(2) microglobulin (β(2)-MG), uric acid (UA), and ScysC before surgery and at 1, 3, 5, 7, 14, 30, and 90 days thereafter. The glomerular filteration rate (GFR) was measured by (99m)Tc-DTPA to evaluate correlations.
RESULTS: No significant difference was observed between the groups before surgery (P > .05). In the rejection-free group ScysC was decreased by 48.1% at 1/day after surgery which was greater than the other cohorts. In the rejection group at day 3 the ScysC increased which was earlier than others. The highest coefficient correlation was observed between ScysC and GFR. The AUC(ROC) of ScysC was greater than all of the others.
CONCLUSION: ScysC was a more sensitive marker to detect changes in renal function than Scr, BUN, β(2)-MG or UA; therefore it can be used to predict an acute rejection episode after transplantation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22663994     DOI: 10.1016/j.transproceed.2012.01.138

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Cystatin C is a moderate predictor of acute kidney injury in the early stage of traumatic hemorrhagic shock.

Authors:  Shu Chen; Jing-Song Shi; Xiaokaiti Yibulayin; Tian-Shan Wu; Xin-Wen Yang; Jie Zhang; Paerhati Baiheti
Journal:  Exp Ther Med       Date:  2015-04-23       Impact factor: 2.447

Review 2.  Cystatin C as a potential biomarker for dosing of renally excreted drugs.

Authors:  Nguessan Aimé Brou; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Br J Clin Pharmacol       Date:  2015-05-28       Impact factor: 4.335

3.  Analysis of Risk Factors for Changes in the Renal Two-Dimensional Image in Gout Patients.

Authors:  Wantai Dang; Xiaohui Xu; Danling Luo; Hui Luo; Jin Hu; Jingguo Zhou; Jian Liu; Lanlan You
Journal:  Int J Gen Med       Date:  2021-10-05

4.  Multicenter study of creatinine- and/or cystatin C-based equations for estimation of glomerular filtration rates in Chinese patients with chronic kidney disease.

Authors:  Jia-fu Feng; Ling Qiu; Lin Zhang; Xue-mei Li; Yu-wei Yang; Ping Zeng; Xiu-zhi Guo; Yan Qin; Hong-chun Liu; Xing-min Han; Yan-peng Li; Wei Xu; Shu-yan Sun; Li-qiang Wang; Hui Quan; Li-jun Xia; Hong-zhang Hu; Fang-cai Zhong; Rong Duan
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

5.  Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19.

Authors:  Yan Li; Shuang Yang; Ding Peng; Hong-Ming Zhu; Bang-Yi Li; Xiaojiao Yang; Xue-Lian Sun; Mei Zhang
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

6.  Establishment of a Drug Screening Model for Cardiac Complications of Acute Renal Failure.

Authors:  Shuyi Liao; Wenmin Yang; Ting Yu; Lu Dai; Xiaoliang Liu; Jiangping Zhang; Jinghong Zhao; Chi Liu
Journal:  Biomolecules       Date:  2021-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.